(MNHs) may enhance targeted drug delivery and tissue engineering in orthopedic applications.
Integration of magnetic nanoparticles (MNPs) into hydrogels improves their dynamic responsiveness and mechanical strength for bone repair.
MNHs utilize superparamagnetic properties of MNPs to allow non-invasive control via external magnetic fields.
MNHs can facilitate on-demand release of antibiotics or growth factors, enhancing targeted drug delivery.
These hydrogels may improve cell-based therapies by retaining mesenchymal stem cells (MSCs) and providing mechanostimulation.
MNHs show potential in anti-infective treatments through to eliminate biofilms.
Clinical translation of MNHs faces challenges including long-term biocompatibility, fabrication scalability, and in vivo magnetic field control.
Simplified
Orthopedic regenerative medicine faces significant challenges in treating critical-sized bone defects, infections, and achieving spatiotemporal therapeutic control. Traditional hydrogels, while providing a biocompatible three-dimensional (3D) environment, often lack the dynamic responsiveness and mechanical strength required for effective bone repair. The integration of magnetic nanoparticles (MNPs), particularly iron oxides (FeO, γ-FeO), into hydrogel matrices has emerged as a transformative strategy to overcome these limitations. These (MNHs) leverage the unique superparamagnetic properties of MNPs to enable remote and non-invasive control over their structure and function via external magnetic fields. This review comprehensively explores the design principles, synthesis methodologies, and multifaceted applications of MNHs in orthopedics. Key advancements discussed include their role in enhancing targeted drug delivery (eg, on-demand antibiotic or growth factor release), facilitating cell-based therapies through magnetic retention and mechanostimulation of mesenchymal stem cells (MSCs), and serving as dynamic scaffolds for bone tissue engineering with improved osteogenic commitment. Furthermore, MNHs exhibit great promise in anti-infective therapies by leveraging to eradicate biofilms and in diagnostic monitoring as contrast agents for MR. Despite their immense potential, clinical translation is contingent upon addressing critical challenges such as long-term biocompatibility of MNPs, scalability of fabrication, and achieving precise in vivo control of magnetic fields. Future perspectives highlight the convergence of MNHs with 4D bioprinting and artificial intelligence (AI) for designing patient-specific, intelligent systems. This review concludes that MNHs represent a paradigm shift towards personalized and adaptive regenerative solutions, poised to redefine treatment strategies in orthopedics and beyond. 3 4 2 3
Full Text
We can’t show the full text here under this license.
